VF
TBIO

Virtu Financial’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Virtu Financial’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-560
Closed -$4K – 2290
2023
Q4 		$4K Buy
+560
New +$6.22K ﹤0.01% 1481
2023
Q1 		– Sell
-1,300
Closed -$29K – 2254
2022
Q4 		$29K Buy
+1,300
New +$35.3K ﹤0.01% 1193

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Virtu Financial's TBIO Position: Q1 2024 in Review

Virtu Financial sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q1 2024, closing a stake of 560 shares — an estimated $4K sold.

Virtu Financial first reported a position in TBIO in Q4 2022 and held it in 2 quarters. The position peaked at $29K in Q4 2022. 20 funds tracked by Wall St. Rank hold TBIO as of Q1 2024.

  • Virtu Financial reported no remaining Telesis Bio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 560 Telesis Bio, Inc. Common Stock shares in Q1 2024, an estimated $4K.
  • Virtu Financial first reported a position in Telesis Bio, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Virtu Financial's Telesis Bio, Inc. Common Stock position peaked at $29K in Q4 2022.
  • 20 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.